Tag:
Celvapan
Latest Headlines
Latest Headlines
GSK's adjuvanted vax beats Baxter shot
In a head-to-head trial of swine flu vaccines, GlaxoSmithKline's (NYSE: GSK) adjuvanted shot outperformed the traditional version from Baxter ( NYSE: BAX ). Children given GSK's Pandemrix--which
Innovative vaccines get EMEA panel approval
Baxter International's H5N1 flu vaccine, Celvapan, received CHMP approval last week, meaning the vaccine could become the first cell culture-based H5N1 influenza vax to hit the market. Celvapan is
Cell-based pandemic vaccine successful in human trial
Baxter International says that a human trial of its Celvapan bird flu vaccine demonstrated that it spurred an immune response against three strains of the lethal virus. This is the first time that
